Bidding Starts for Allscripts (MDRX, BX, CG)
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Allscripts has had a turbulent year. In April the company fired its chairman (and former CEO), the CFO resigned and three directors left — all on the same day. The impetus for the move came from a major shareholder, Healthcor Management, which placed three of its candidates on the board following the massacre.
Shares of Allscripts fell below $10 that day, and have managed to come back to north of $13 as of last Friday. At least one analyst put a target price of $15 on Allscripts the day it announced it would explore a sale of the company. Before the April disaster, the stock was trading at $16 and the 52-week high is over $21 a share. The trailing P/E is nearly 43, but the forward P/E is just over 14. The consensus target price is just $12.62.
The move to electronic health records under Obamacare makes Allscripts a valuable property. Just guessing here, but a buyout at $15 looks too cheap. And this company almost certainly will go to the highest bidder.
Shares of Allscripts closed at $13.33 on Friday, in a 52-week range of $8.84 to $21.66. Shares are up 5.8% in premarket trading this morning, at $14.10.
Paul Ausick
Contact [email protected] for any questions or corrections.





